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Phosphorylation of the regulatory light chain of myosin II (MLC20) at the activation sites promotes both the motor activity
and the filament formation of myosin II, thus playing an important role in various cell motile processes. In contrast, the
physiological function of phosphorylation of MLC20 at the inhibitory sites is unknown. Here we report for the first time
the function of the inhibitory site phosphorylation in the cells. We successfully produced the antibodies specifically
recognizing the phosphorylation sites of MLC20 at Ser1, and the platelet-derived growth factor (PDGF)-induced change
in the phosphorylation at the Ser1 was monitored. The phosphorylation of MLC20 at the Ser1 significantly increased
during the PDGF-induced actin cytoskeletal reorganization. PDGF disassembled the stress fibers, and this was attenuated
with the expression of unphosphorylatable MLC20 at the Ser1/Ser2 phosphorylation sites. The present results suggest that
the down-regulation of myosin II activity achieved by the phosphorylation at the Ser1/Ser2 sites plays an important role
in the normal reorganization of actomyosin filaments triggered by PDGF receptor stimulation.
INTRODUCTION
Cell migration plays a key role in both the physiological and the
pathophysiological function of the cells including development,
wound healing, immunity, and metastasis (Lauffenburger and
Horwitz, 1996). Reorganization of actomyosin filaments is an
essential process for these cell behaviors. It has been thought
that myosin II plays a fundamental role in various types of
cellular motility.
In vitro biochemical studies have revealed that the func-
tion of smooth muscle and nonmuscle myosin II is regulated
by the phosphorylation of MLC20 (Sellers, 1991; Tan et al.,
1992). A number of studies have shown that the phosphor-
ylation of MLC20 at Thr18 and Ser19 activates its motor
activity and increases filament stability. On the other hand,
it has been known that MLC20 can be phosphorylated at
other sites different from the activation sites. Originally, it
was found that protein kinase C (PKC) phosphorylates
Ser1/Ser2 and Thr9 of MLC20. This phosphorylation de-
creases the affinity of myosin II phosphorylated at the acti-
vation sites for actin and the affinity of MLC20 for myosin
light-chain kinase (MLCK; Nishikawa et al., 1984; Bengur
et al., 1987; Ikebe et al., 1987; Ikebe and Reardon, 1990). In
other words, the phosphorylation of MLC20 at these sites
inhibits rather than activates myosin II.
It was reported that the phosphorylation of MLC20 at the
Thr9 inhibits myosin II motor activity and the phosphory-
lation of MLC20 by MLCK (Nishikawa et al., 1984; Turbedsky
et al., 1997); however, phosphorylation of the inhibitory sites
in nonmuscle cells has only been observed on Ser1 and/or
Ser2, but not on Thr9 in vivo (Kawamoto et al., 1989; Yamakita
et al., 1994), and this is because the Ser1/Ser2 sites are resistant
to dephosphorylation by myosin light chain phosphatases
while phospho-Thr9 is readily dephosphorylated (Ikebe et
al., 1999). Furthermore, it has been demonstrated that the
phosphorylation of Ser1/Ser2 sites significantly inhibits its
motor activity (Ikebe et al., 1987). Therefore, it is anticipated
that the phosphorylation of Ser1/Ser2 sites has a role in
regulating myosin II function in cells. The phosphorylation
of MLC20 at Ser1/Ser2 but not Tht9 was observed during
mitosis in mammalian cultured cells (Yamakita et al., 1994).
However, the expression of unphosphorylatable MLC20 at
the inhibitory sites did not affect the progression of oogen-
esis in Drosophila embryos (Royou et al., 2002). Therefore, it
is unclear whether phosphorylation of MLC20 at the inhibi-
tory sites is involved in down-regulation of myosin II activ-
ity during Drosophila oogenesis. Although it is anticipated
that the down-regulation of myosin II activity by the phos-
phorylation at the inhibitory sites may be important for cell
motile events, the physiological significance of this inhibi-
tory phosphorylation of myosin II on myosin function in the
cells has not been well understood.
To clarify the cellular functions of the inhibitory site phos-
phorylation of myosin II, we developed a site-specific anti-
phosphoamino acid antibody (pSer1 Ab) that specifically
recognizes the phosphorylated MLC20 at the inhibitory sites
(Ser1) but not the activation sites. By using this probe, we
succeeded in monitoring the spatio-temporal change in my-
osin II phosphorylated at the Ser1/Ser2 site(s) after external
stimuli. We found that the stimulation of platelet-derived
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growth factor (PDGF) mediated a transient phosphorylation
of MLC20 at the Ser1/Ser2 site(s). The increase in phosphor-
ylation at the inhibitory sites coincided with the PDGF-
induced disassembly of stress fibers. Expression of unphos-
phorylatable MLC20 at the Ser1/Ser2 sites diminished the
disassembly of stress fibers and focal adhesions in 3T3 fi-
broblasts. These results demonstrate that the phosphoryla-
tion at the Ser1/Ser2 sites of MLC20 regulates the dynamics
of actomyosin filament formation in cells.
MATERIALS AND METHODS
Materials
Smooth muscle myosin II (Ikebe and Hartshorne, 1985a), MLCK, and protein
kinase C (PKC; Ikebe et al., 1987) were prepared as described previously. Actin
was prepared from rabbit skeletal muscle according to the method of Spudich
and Watt (1971). LY294002, PD98059, and the PKC inhibitors, GF109203X,
Go6976, and Rottlerin, were purchased from EMD Chemicals, Inc. (San Diego,
CA).
Antibodies
The N-terminus acetylated phosphopeptide phoshoS SKRAKTC was coupled
to keyhole limpet hemocyanin at the C-terminal cysteine residue by Genmed
Synthesis (South San Francisco, CA). A pSer1 antibody (Ab) was affinity-
purified using the phosphopeptide and then absorbed with an unphos-
phopeptide. A pSer19 Ab and pTS Ab specifically recognized the phosphor-
ylated MLC20 at Ser19 and di-phosphorylated MLC20 at Thr18 and Ser19,
respectively (Komatsu et al., 2000; Komatsu and Ikebe, 2004). Anti-MLC20
antibodies were from Sigma (M4401, St. Louis, MO) and Santa Cruz Biotech-
nology (sc-15370, Santa Cruz, CA), and anti-Myc, -paxillin, -myosin II Abs
were purchased from Sigma-Aldrich, Santa Cruz Biotechnology, Transduc-
tion Laboratories (Lexington, KY), and Covance Research Products (Madison,
WI). A rabbit Ab against heavy chain of myosin IIB and MLC20 were kindly
provided by Dr. R. Adelstein (National Institutes of Health, Bethesda, MD)
and Dr. J. Stull (University of Texas SW Medical Center).
Cell Stimulation
NIH3T3 fibroblast cells were maintained in DME containing 10% newborn
calf serum. For PDGF and 12-O-tetradecanoylphorbol-13-acetate (TPA) stim-
ulations, NIH3T3 or MEF/3T3 Tet-Off cells were cultured for 18 h in DME
supplemented with 0.1% newborn calf serum or 0.1% fetal bovine serum
(FBS). Serum-starved cells were treated with either PDGF or TPA.
Biochemical Procedures
Urea/glycerol gel electrophoresis (Perrie and Perry, 1970) and SDS-PAGE
(Laemmli, 1970) were carried out as described. MLC20 was phosphorylated by
MLCK and PKC as described (Ikebe and Hartshorne, 1985a; Ikebe et al., 1987).
To analyze the fraction of the expressed MLC20 incorporated into myosin II,
we have used an ATP-dependent actin-binding activity of myosin II as
described previously (Homma et al., 2000; Wei and Adelstein, 2000) with
slight modifications. MEF/3T3 cells expressing myc-tagged MLC20s were
lysed in buffer I (50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 5 mM MgCl2, 2 mM
EGTA, 1 mM dithiothreitol, 0.2 mM N--p-tosyl-l-lysine chloromethl ketone
[TLCK], 0.2 mM tosyl-phenylalanyl chloromethyl ketone [TPCK], 10 g/ml
leupeptin, 2 mM phenylmethylsulfonyl fluoride, and 0.01% IGEPAL CA-630)
with 2 mM ATP by sonication. The lysates were centrifuged at 270,000 g for
15 min. The supernatants were incubated with 50 mM glucose, 20 U/ml
hexokinase, and 0.2 mg/ml rabbit skeletal F-actin on a rotary mixer at 4°C for
30 min to completely hydrolyze residual ATP and coprecipitate myosin II
with F-actin. After the reaction solutions were centrifuged at 270,000  g for
15 min, the pellets were resuspended with buffer I without ATP and then
centrifuged at 27,000  g for 10 min. After washing once more with buffer I,
the pellets were resuspended with buffer I containing 5 mM ATP to release
myosin II from F-actin. After centrifugation at 270,000  g for 10 min, the
supernatants were subjected to Western blot analysis. Immunoblotting was
done as described using nitrocellulose membranes (Yano et al., 1993; Komatsu
et al., 2000).
Immunofluorescence Staining and Image Processing
Immunocytochemistry was performed as described (Komatsu et al., 2000).
Fluorescence images were viewed using a Leica DM IRB laser scanning
confocal microscope controlled by Leica TCS SP II systems (Leica Microsys-
tems, Heidelberg, Germany). All images were taken with same laser output to
directly compare the fluorescence signal intensities. Relative fluorescence
intensities of pSer1 in the whole cells areas were measured with Leica TCL
SP2 software as described (Komatsu et al., 2002). Images were processed using
Adobe Photoshop 5.5 software (Adobe Systems, San Jose, CA).
Quantification Analysis
For quantification of stress fiber formation, more than 100 cells in the ran-
domly chosen fields were recorded blindly by a confocal fluorescence micro-
scope, and the percentage of cells having stress fibers was calculated. The
values shown are means  SD from three independent experiments (more
than 100 cells/experiment). For quantification of focal adhesions (FAs), the
number and the size (area) of FAs were determined by “Particle analysis”
function in ImageJ (Cai et al., 2006). The FAs were determined by quantifying pixels
in cells stained with Ab against paxillin. We defined paxillin foci 6–30 pixels
(3.22–16.05 m2) as large FAs and 1–5 pixels (0.535–2.675 m2) as small FAs.
Statistical Analysis
All statistical analyses were performed with a Student’s t test tool.
Plasmid Construction, Conditional Cell Lines,
and Transfection
Mutant MLC20 in which PKC phosphorylation sites (Ser1 and Ser2) were
mutated to Ala was made by site-directed mutagenesis (Yano et al., 1993).
Nonmuscle human myosin IIB heavy-chain cDNA was received as a gift from
Dr. R. Adelstein (National Institutes of Health) and cloned into pEYFP-C1
plasmid (Clontech, Palo Alto, CA). To delete the C-terminal amino acid
residues of the human myosin IIB heavy chain, a stop codon was created at
the codon 1898 for C-Myosin IIB.
MEF/3T3 Tet-Off cells, which can be suppressed expression of fusion
proteins in the presence of doxycycline, were grown in DMEM supplemented
with 10% FBS. MLC20swere subcloned into pTRE2-Hyg (Clontech) containing
a myc tag sequence. The myc tag sequence was introduced at the C-terminal
end of MLC20. To obtain stably expressed MLC20-myc cell lines, colonies were
maintained in 0.25 mg/ml G418, 0.25 mg/ml hygromycin, and 2 g/ml
doxycycline (Invitrogen Invitrogen, BD Biosciences, Clontech).
For transient transfection, NIH3T3 cells on a coverslip were transfected
with Lipofectamine 2000 transfection reagent (Invitrogen) according to the
protocol provided by the manufacturer. For transfection of stable cell lines,
MEF3T3 Tet-Off cells were transfected with electroporation using a Gene
Pulser II (Bio-Rad Laboratories, Richmond, CA; Komatsu et al., 2000).
RESULTS
Production of Inhibitory Site-specific Antibody
To monitor the extent and the spatial distribution of MLC20
phosphorylation at the inhibitory sites, we generated the
phosphorylation site-specific antibodies. Because the phos-
phorylation of MLC20 at the inhibitory sites has only been
observed on Ser1/2 but not on Thr9 in cells (Kawamoto et
al., 1989; Yamakita et al., 1994), we produced the antibodies
(pSer1 Ab) that raised against the N-terminal serine phos-
phorylation. The specificity of pSer1 Ab was examined by
immunoblot analysis. Myosin II was phosphorylated by ei-
ther MLCK or PKC, and the unphosphorylated, mono-, and
diphosphorylated MLC20s were separated by urea/glycerol
gel electrophoresis (Figure 1A, left), followed by immuno-
blotting with pSer1 Ab (Figure 1A, right). MLCK phosphor-
ylated MLC20 to yield monophosphorylated MLC20 with
minor di-phosphorylated MLC20. This represents the phos-
phorylation at Ser19 and Ser19/Thr18, respectively (Ikebe
and Hartshorne, 1985b). On the other hand, PKC produced
monophosphorylated MLC20 that is composed of MLC20
containing phospho-Thr9, phospho-Ser1, and phospho-Ser2,
respectively (Ikebe et al., 1987). The pSer1 Ab only recog-
nized the phosphorylated MLC20 of myosin II by PKC, but
not phosphorylated MLC20 by MLCK and unphosphory-
lated MLC20. To examine whether pSer1 antibodies are spe-
cific to the N-terminal serine sites, we produced a S1A/S2A
MLC20 mutant. The mutant was incubated with PKC for
phosphorylation and subjected to Western blot analysis us-
ing pSer1 Ab. Although PKC phosphorylated the mutant
MLC20, presumably at Thr9, the pSer1 Ab did not react with
the S1A/S2A MLC20 mutant incubated with PKC (Figure
1B), indicating that pSer1 Ab recognized the phosphorylated
MLC20 at the N-terminal serine sites but not Thr9 (Turbed-
sky et al., 1997; Varlamova et al., 2001). Figure 1C shows the
Western blot of whole cell lysates of mammalian cultured
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cells using pSer1 Ab. Serum-starved cultured cells were
stimulated with 200 nM TPA to activate PKC, and the
change in the signal detected by pSer1 Ab was monitored.
The pSer1 Ab recognized a band corresponding to the mo-
lecular weight of MLC20 only after TPA stimulation of the
cells, indicating that the antibodies are highly specific to the
phosphorylated MLC20 at the N-terminal serine.
Phosphorylation of MLC20 at the Ser1/Ser2 Sites
Correlates with PDGF-induced Disassembly of the Stress
Fibers
To investigate the role of phosphorylation of myosin II at the
inhibitory sites on myosin function during cell motility, the
serum-starved NIH3T3 cells were stimulated with PDGF, a
potent stimulator of cell motility that is implicated in the
activation of PKC pathway (Heldin et al., 1998). The level of
MLC20 phosphorylation at Ser1 was examined by both im-
munostaining and immunoblotting of NIH3T3 cells with
pSer1 Ab (Figure 2, A–C). Immunofluorescence images of
the serum-starved NIH3T3 cells probed by pSer1 Ab showed
the weak filamentous localizations of myosin II phosphory-
lated at Ser1/Ser2 sites of MLC20, and this was colocalized with
myosin II filaments as well as actin stress fibers (Figure 2A, a,
e, and i). It should be noted that the staining of the nucleus, in
addition to the filamentous structures, was also observed in the
serum-starved cells, suggesting that the phosphorylated
MLC20 at Ser1/Ser2 seems to be present in the nucleus. This
observation is similar to the previous reports that the phos-
phorylated MLC20 was found in the nucleus (Matsumura et
al., 1998; Nagano et al., 2006). After PDGF stimulation, the
disassembly of the stress fibers was observed (Figure 2A,
j–l). Interestingly, the MLC20 phosphorylation at Ser1/Ser2
sites was markedly increased by PDGF and reached the
maximum at 30 min after the stimulation (Figure 2B, top
panel). The majority of the cells showing the disassembly of
stress fibers is consistent with the time course of maximum
phosphorylation of Ser1/Ser2 sites determined by Western
blot analysis (Figure 2B). It should be mentioned that some
cells showed the disassembly of stress-fibers at earlier times.
These cells showed a relatively high level of phosphoryla-
tion of MLC20 at Ser1/Ser2 sites revealed by pSer1 Ab stain-
ing. The level of phosphorylated MLC20 at the activation
sites was detected by two phospho-antibodies (pSer19 Ab
and pTS Ab), which specifically recognized the phosphory-
lated MLC20 at Ser19 and di-phosphorylated MLC20 at Thr18
and Ser19, respectively (Komatsu et al., 2000; Komatsu and
Ikebe, 2004). Phosphorylation of MLC20 at the Ser19 did not
increased after PDGF stimulation. The di-phosphorylated
MLC20 at the activation sites was slightly elevated upon
PDGF stimulation, but it was sustained thereafter (Figure
2B, middle panels). To monitor the level of phosphorylated
MLC20 at the inhibitory and activation sites, the total ho-
mogenates were subjected to alkali-urea and glycerol gel
electrophoresis (Figure 2C). The amount of phosphorylated
MLC20s at each site was estimated from the PDGF-induced
change in the amount of phosphorylation at each site (Figure
2B) and the change in the singly and doubly phosphorylated
MLC20 determined by the alkali-urea/glycerol PAGE (Fig-
ure 2C). The total amount of phosphorylated MLC20 before
PDGF stimulation was 7.4  1.6% of the total MLC20
estimated by alkali/urea gel (Figure 2C, lane 1). On the other
hand, the total amount of phosphorylated MLC20 (mono-
phosphorylated MLC20  diphosphorylated MLC20) after
PDGF stimulation was 38.7  2.2% of the total MLC20
(Figure 2C, lane 2). Although PDGF stimulation significantly
increased the phosphorylated MLC20 at Ser1, it rather de-
creased the phosphorylated MLC20 recognized by pSer19Ab
(Figure 2B). It should be noted that the pSer19Ab recognizes
both singly and doubly phosphorylated MLC20 at the acti-
vation sites (Komatsu et al., 2000); therefore, the result sug-
gests that the total extent of phosphorylation at the activa-
tion sites was relatively decreased after PDGF stimulation.
Because the amount of phosphorylation at Ser1 before PDGF
stimulation was at a negligible level, the observed mono-
phosphorylated MLC20 at rest should be predominantly at-
tributed to phosphorylated MLC20 at Ser19. The amount of
phosphorylated MLC20 at the activation site (Ser19) at 30
min after PDGF stimulation was 80% of that before PDGF
stimulation (7.4 1.6%; Figure 2B); therefore, it is calculated
that more than 30% of the total MLC20 was phosphorylated
at the Ser1/Ser2 sites after PDGF stimulation (38.7  2.2
[PDGF]  0.8  (7.4  1.6) [Control]). The results suggest
Figure 1. Specificity of pSer1 Ab against the phosphorylated reg-
ulatory light chain of myosin II. (A) Unphosphorylated (0-p) and
phosphorylated MLC20 (1-p and 2-p) of myosin II either by MLCK
or PKC were separated by alkali-urea/glycerol gel (left panel, Pon-
ceau S staining), followed by immunoblotting with pSer1 Ab (right
panel). Lane 1, unphosphorylated MLC20; lane 2, phosphorylated
MLC20 by MLCK; and lane 3, phosphorylated MLC20 by PKC. ELCs,
essential light chains. (B) Immunoblot analysis with pSer1 Ab was
carried out for wild-type MLC20 (Wt) and S1A/S2A MLC20 (AA).
Both wild-type MLC20 and S1A/S2A MLC20 were incubated with
PKC in the presence of Mg2-ATP, and the sample was analyzed by
immunoblotting with pSer1 Ab. (C) Immunoblot of the whole ly-
sates of TPA stimulated cells with pSer1 Ab. After serum starvation,
REF-2A fibroblasts, CHO-K1, NIH3T3, or NRK52E epithelial cells
were treated with 200 nM TPA or 0.1% DMSO (control) for 15 min,
and then the whole cell lysates were subjected to immunoblotting
with pSer1 Ab.
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that a significant fraction of MLC20 was phosphorylated at
the Ser1/Ser2 sites after PDGF stimulation.
Consistent with the Western blot data, the intensity of
immunofluorescence signals of pSer1 Ab in the whole cells
areas was significantly increased after PDGF stimulation
(Figure 2A). The increase in the signal intensity was 1.4-,
3.5-, and 2.2-fold, at 10, 30, and 60 min after the stimulation
(n  10), respectively. It should be noted that the signal
intensity observed in Figure 2, A–D, looks high, but this is
because the cells changed their shapes and significantly
decreased their cell volumes. These results suggest that the
phosphorylation of the Ser1/Ser2 sites of MLC20 is involved
in the PDGF-induced reorganization of actomyosin fila-
ments.
PKC/ Is Required for the PDGF-mediated Inhibitory
Phosphorylation of MLC20
The PDGF signaling pathways have been implicated in cell
growth and motility coupling with the activation of protein
kinases such as phosphatidylinositol 3 kinase (PI3K), p42/
p44 mitogen-activated protein kinases (MAPKs), and the
PKC family (Heldin et al., 1998). To determine which of the
signaling pathways triggered by PDGF stimulation are re-
sponsible for MLC20 phosphorylation at the inhibitory sites,
NIH3T3 cells were pretreated with various kinase inhibitors
and the effect on the MLC20 phosphorylation at the inhibi-
tory sites was examined. Among the inhibitors tested, only
the PKC inhibitor GF109203X, having a broad inhibitory
spectrum against PKC isoforms, diminished the PDGF-me-
diated MLC20 phosphorylation at Ser1 (Figure 3A). This
result indicates that PKC pathways are responsible for the
PDGF-mediated phosphorylation of MLC20 at the inhibitory
sites.
To verify which PKC isoforms are responsible for the
PDGF-mediated phosphorylation of MLC20 at the inhibitory
sites, NIH3T3 cells were pretreated with various PKC inhib-
itors having distinct isoenzyme specificities. The cells were
examined either by Western blot or under a fluorescent
microscope. The decrease in MLC20 phosphorylation at the
inhibitory sites by PKC/ specific inhibitor (Go6976) as
Figure 2. PDGF mediates the phosphoryla-
tion of MLC20 at Ser1 in cells. (A) NIH3T3 cells
were treated with PDGF (20 ng/ml) as de-
scribed in Materials and Methods for the indi-
cated times. Top and bottom panels show the
confocal microscopic images of cells stained
with pSer1 Ab (a–d), Myosin II Ab (e–h), and
Alexa Fluor546-phalloidin (i–l). The focal
plane is close to the bottom of the cell. Bar, 25
m. (B) Immunoblot of PDGF-stimulated cell
lysates with pSer1 Ab, pSer19 Ab, pTS Ab, and
MLC20 Ab. The whole cell lysates of PDGF-
stimulated cells were subjected to SDS-PAGE
followed by immunoblotting with pSer1 Ab,
pSer19 Ab, pTS Ab, and MLC20 Ab. Right, the
amount of phosphorylated MLC20 was deter-
mined by scanning densitometry (NIH image pro-
gram). (C) Amount of phosphorylated MLC20 at
the inhibitory sites and the activation sites.
NIH3T3 cells were treated with 20 ng/ml PDGF
for 30 min (lane 2) and then subjected to alkali-
urea/glycerol gel electrophoresis, followed by
immunoblotting with anti-MLC20 Ab (lane 1,
control; untreated cells). Right, the fraction of
phosphorylated MLC20 was determined by
scanning densitometry (NIH image program).
The values shown are means  SD from three
independent experiments.
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well as GF109203X was found by Western blot analysis
(Figure 3B). Consistent with this result, the decrease in the
stress fibers after 30 min of PDGF stimulation was rescued
by these inhibitors (Figure 3C). In contrast, Rottlerin, a PKC
preferential inhibitor, failed to decrease the MLC20 phos-
phorylation (Figure 3B) and did not rescue the stress fiber
disassembly induced by PDGF (Figure 3Cl). These results
strongly suggest that Ca2-dependent PKC isoforms (PKC/)
play a critical role in the PDGF-induced disassembly of stress
fibers via myosin II phosphorylation at the inhibitory sites.
Phosphorylation of MLC20 at Ser1/Ser2 Sites Is Involved
in the Regulation of the Disassembly of Stress Fibers
Induced by PDGF Receptor Stimulation
To study the role of phosphorylation of MLC20 at the inhib-
itory sites on the disassembly of stress fibers, we produced
stably transfected MEF/3T3 Tet-Off cell lines expressing
myc-tagged MLC20s. The reconstitution of myc-tagged
MLC20 to myosin II was analyzed by using an ATP-depen-
dent actin-binding property of myosin II (see Materials and
Methods for details). As shown in Figure 4, both wild-type
and S1A/S2A MLC20 stable cell lines were cultured in the
presence or absence of doxycycline (Dox) and were sub-
jected to an actin-binding assay. The expression level of
myc-tagged MLC20 in each clone was 80% of the total
MLC20, respectively (Figure 4, left panel: Cell lysates). The
amount of myc-tagged MLC20 incorporated into myosin II
was 3.5 times higher than that of endogenous MLC20
(Figure 4, right panel). Furthermore, the localization of the
myc-tagged MLC20 signal showed filamentous localization
that coincides with the localization of F-actin (Figure 5, A
and B). The result indicates that myc-tagged MLC20 was
effectively incorporated into myosin II in the stress fibers.
To evaluate the role of the phosphorylation of MLC20 at
the inhibitory sites on the disassembly of the stress fibers,
the MEF/3T3 Tet-Off cells, expressing either wild-type or
S1A/S2A MLC20, were cultured for 3 d without Dox to
induce the expression of myc-tagged MLC20s. As shown in
Figure 5, the cells expressing S1A/S2A MLC20 (Figure 5B,
a–c) as well as those expressing wild-type MLC20 (Figure
5A, a–c) showed filamentous localization of MLC20. This
coincides with the localization of F-actin, indicating that the
mutation at Ser1/Ser2 sites of MLC20 does not change the
myosin II localization before PDGF stimulation. After 40
min of PDGF stimulation, the cells expressing the wild-type
MLC20 showed the disassembly of stress fibers, accompa-
nied by the decrease in the number of focal adhesion (Figure
5A, d–f). In contrast, the PDGF-induced disassembly of
stress fibers was attenuated in the cells expressing the un-
phosphorylatable S1A/S2A MLC20 (Figure 5B, d–f). On the
other hand, the majority of the cells in the presence of Dox,
thus inhibiting the expression of S1A/S2A MLC20 showed
the disassembly of stress fibers (Figure 5B, g–i). The fraction
of the cells forming the stress fibers in the control cells was
32.7  2.0 and 29.6  3.6% in the presence and absence of
Dox, respectively, after PDGF stimulation (Figure 5C).
On the other hand, a significant increase in the stress fiber
formation was observed for the cells expressing S1A/S2A
MLC20 at 40 min after PDGF stimulation. The fraction of the
cells forming the stress-fibers was 21.0  5.3% before the
expression of S1A/S2A MLC20, and the value was signifi-
cantly increased to 45.3  1.5% (p  0.003, t test; Figure 5C).
We also quantified focal adhesions in controls versus S1A/
S2A MLC20-expressing cells and found that the number of
large focal adhesions was significantly different between the
controls and S1A/S2A MLC20-expressing cells after PDGF
stimulation. PDGF stimulation decreased the number of the
large focal adhesions (3.22–16.05 m2), but the decrease in
the number was reduced by the expression of S1A/S2A
MLC20 (p  0.02, t test; Figure 5D).
Figure 3. Effect of the protein kinase inhibitors on the PDGF-
mediated Ser1 phosphorylation. (A) Immunoblotting of PDGF-stim-
ulated NIH3T3 cells in the presence of various kinase inhibitors. Se-
rum-starved NIH3T3 cells were preincubated with the protein kinase
inhibitors for 10 min (3 M GF109203X, PKC inhibitor; 10 M
LY294002, PI3K inhibitor; 50 M PD98059, MEK inhibitor; and
SB203580, p38 MAP kinase inhibitor; respectively) before PDGF (20
ng/ml) stimulation. The reaction was stopped at 30 min after stimu-
lation, and the whole cell lysates were subjected to immunoblot anal-
ysis with pSer1 Ab (top panel) and MLC20 Ab (bottom panel), respec-
tively. NC, no treatment with PDGF; control, 0.1% DMSO. (B)
Immunoblotting of PDGF-stimulated NIH3T3 cells in the presence of
PKC inhibitors. Serum-starved NIH3T3 cells were treated with 20
ng/ml PDGF for 30 min in the presence of 0.1% DMSO (control), 3 M
GF109203X, 1 M or 100 nM Go6976, or 1 M Rottlerin. Cells were
preincubated with the PKC inhibitors for 10 min before cell stimula-
tion. The whole cell lysates were subjected to Western blotting with
pSer1 Ab (top panel) and MLC20 Ab (bottom panel), respectively. NC,
no treatment with PDGF. (C) Immunostaining of PDGF-stimulated
NIH3T3 cells in the presence of PKC inhibitors. Serum-starved NIH3T3
cells were treated with 20 ng/ml PDGF for 30 min under the same
condition as in B. The cells were stained with pSer1 Ab (a–d), Myosin
II Ab (e–h) and Alexa Fluor546-phalloidin (i–l). Bar, 25 m.
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On the other hand, the decrease in the small focal adhe-
sions (0.535–2.675 m2) after the stimulation was not signif-
icantly different between controls and S1A/S2A MLC20-
expressing cells (p 0.2870, 0.168, and 0.150 [Wt (Dox/)
vs. S1A/S2A and S1A/S2A; Dox () versus ()], t test;
Figure 5D). Similar results were obtained when NIH3T3
cells were transiently transfected with S1A/S2A MLC20-
expressing vector. At 40 min after PDGF stimulation, the
wild-type MLC20-transfected cells showed the disassembly
of stress fibers accompanied with the decrease in the number
of focal adhesion (not shown). In contrast, the expression of
S1A/S2A MLC20 significantly attenuated the PDGF-induced
disassembly of the stress fiber compared with the cells trans-
fected with the wild-type MLC20 (not shown). The fraction
of the cells forming the stress fibers in the wild-type trans-
fected cells was 3.4  1.5% (n  150; 40–60 transfected cells
analyzed in three independent experiments) at 40 min after
PDGF stimulation. The value was the same as that of the
nontransfected cells (4.0  2.5%, n  174). On the other
hand, a significant increase in the stress fiber formation was
observed for the cells transfected with S1A/S2A MLC20
(17.4 0.7%; n 150, p 0.008, t test). These results further
support the idea that the phosphorylation of MLC20 at Ser1/
Ser2 sites affects the stability of stress fibers, thus contribut-
ing to the morphological changes induced by PDGF.
Effect of Heavy-Chain Phosphorylation on the
Disassembly of Stress Fibers
Previous studies have reported that PKC phosphorylates the
heavy chains of nonmuscle myosin IIB in the nonhelical
tailpiece, resulting in the inhibition of the assembly of my-
osin IIB into filaments in vitro (Murakami et al., 1998;
Bresnick, 1999). Although it is not known if PDGF stimula-
tion induces the phosphorylation of myosin IIB heavy chain,
we examined whether the heavy-chain phosphorylation is
involved in the regulation of the disassembly of stress fibers
in cells. NIH3T3 cells were transfected with yellow fluores-
cent protein (YFP)-tagged C-Myosin IIB in which the non-
helical tail sequence containing multiple phosphorylation
sites is deleted (Murakami et al., 1990, 1998). The expression
level of wild-type and C-Myosin IIB in cells was estimated
by measuring the fluorescence intensity of YFP signals, and
the cells that expressed a similar level of the wild-type or
C-Myoisn IIB were used for the experiment. The amount of
myosin II filaments in the cell expressing exogenous wild-
type myosin IIB was estimated by staining with anti-myosin
heavy-chain IIB antibodies. The signal intensities were about
three times higher than that of endogenous myosin IIB in the
untransfected cells, suggesting that the expressed wild-type
myosin IIB was incorporated into the myosin filaments. We
could not use the myosin IIB–specific antibodies to detect
the incorporation of C-Myoisn IIB into filaments, because
the antibodies recognize the nonhelical tail domain (Phillips
et al., 1995). However, because YFP-myosin IIB with and
without the nonhelical tail were incorporated into the fila-
ments with similar extent, it is expected that C-Myoisn IIB
is also incorporated into the filaments. Before the PDGF
stimulation, both the wild-type and C-Myosin IIB–trans-
fected cells showed filamentous localization that coincided
with the stress fibers (Figure 6A, a, e, and c, g). After 30 min
of PDGF stimulation, the filamentous localization of myosin
IIB was diminished that correlated with the disassembly of
the stress fibers (Figure 6A, b, f, and d, h). The number of
cells showing PDGF-induced disassembly of stress fibers
was not significantly different between wild-type and C-
Myosin IIB–expressing cells (p 	 0.98, t test; Figure 6B). The
role of the phosphorylation at the inhibitory sites of MLC20
and the heavy-chain phosphorylation at the tail nonhelical-
piece on the formation of the myosin filament structures is
discussed in the Discussion.
DISCUSSION
Actomyosin contractility in nonmuscle cells plays a funda-
mental role in various types of cellular motility including
cell migration and cell division (Lauffenburger and Horwitz,
1996; Geiger and Bershadsky, 2001; Matsumura, 2005). De-
spite the abundant research of myosin II functions coupled
with phosphorylation of MLC20 at the activation sites, little
is known about the phosphorylation of MLC20 at the inhib-
itory sites. The present study provides the first evidence that
the phosphorylation of MLC20 at Ser1/Ser2 sites plays an
important role in the normal reorganization of actomyosin
structures induced by the stimulation of PDGF signaling.
Because PDGF stimulation could activate various protein
kinase pathways (Heldin et al., 1998), we attempted to iden-
tify the kinase responsible for the PDGF-mediated phos-
phorylation of MLC20 at the inhibitory sites in cells. Using
the various types of kinase-specific inhibitors, we found that
PKC but not PI3 kinase and MAPKs is responsible for the
phosphorylation. Furthermore, our results suggest that the
phosphorylation of MLC20 at the inhibitory sites is mediated
by conventional PKC isoforms / (Figure 3). Supporting
this observation, as previously reported, conventional PKC
is the major kinase responsible for the inhibitory phosphor-
ylation of MLC20 in mitotic extracts (Varlamova et al., 2001).
It was originally reported that the cdc2 kinase is responsible
for the phosphorylation of MLC20 at the inhibitory sites in
mitosis (Satterwhite et al., 1992); however, it was subse-
quently reported that there are kinases other than cdc2
kinase responsible for the phosphorylation of MLC20 at the
inhibitory sites in mitotic cells from mammalian cultured
cells (Yamakita et al., 1994) and sea urchin eggs (Komatsu et
al., 1997). An in vitro biochemical study has shown that
Figure 4. Inducible expression of myc-tagged
wild-type or S1A/S2A MLC20 in the stable
transfectants. MEF/3T3 Tet-Off cells were cul-
tured with () or without () doxycycline (Dox)
to suppress or induce the expression of myc-
tagged wild-type or S1A/S2A MLC20. Myosin II
having endogenous and/or expressed MLC20s
in cell lysates were coprecipitated with F-actin
(see Materials and Methods for details). After re-
leasing myosin II from F-actin by ATP, the su-
pernatants were subjected to immunoblot, and
the signals were detected with Myosin II Ab,
MLC20 Ab, and myc Ab.
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PKC has approximately threefold greater catalytic activity
than PKC for MLC20 as a substrate and that PKC phos-
phorylates Ser1/2 and Thr9 of MLC20, whereas PKC pre-
dominantly phosphorylated Thr9 of MLC20 (Varlamova et
al., 2001). Furthermore, PKC is the most abundant conven-
tional PKC isoforms in the NIH3T3 cells (Goodnight et al.,
1995). Therefore, we concluded that the phosphorylation of
MLC20 at the inhibitory sites upon PDGF stimulation is
predominantly catalyzed by conventional PKC.
It was previously reported that expression of the charge
reversal form of the MLC20 mutant at the activation sites
(substitution of Thr18 and Ser19 by Asp) promotes stable
stress fiber formation in NIH3T3 cells (Amano et al., 1998)
and that the increase in MLC20 phosphorylation at the
activation sites, via inhibition of myosin phosphatase,
induces both formation of stress fibers and focal adhe-
sions (Totsukawa et al., 2000). In addition, the mutation of
the activation sites of MLC20 to unphosphorylatable resi-
dues (S19A/Thr18/A) results in the inhibition of the myosin
II contractile activity (Komatsu et al., 2000) and the reduction
of the number of actomyosin filaments (Komatsu and Ikebe,
unpublished observations). These results suggest that the
activation of the myosin activity is critical to induce the
formation of myosin filaments and necessary to maintain the
structure of stress fibers and focal adhesions (Figure 7A).
Recently it was reported that PDGF stimulation triggers
the transient phosphorylation of Rho GTPase family mem-
ber RhoE in NIH3T3 cells (Riento et al., 2005) and proposed
that RhoE phosphorylation increases the stability of RhoE
protein resulting in the disruption of stress fibers through
Figure 5. Effect of the phosphorylation of MLC20 at the inhibitory
sites on the disassembly of stress fibers in MEF/3T3 Tet-Off cells.
MEF/3T3 Tet-Off cells were cultured in the absent of doxycycline
(Dox) to induce the expression of myc-tagged wild-type or S1A/
S2A MLC20. After 3 d, the cells were serum-starved for 18 h and
then treated with PDGF for 40 min, followed by immunostaining
with myc Ab, paxillin Ab, and Alexa Fluor546-phalloidin. Bar, 30
m. (A) Immunostainig of MEF/3T3 Tet-Off cells expressed with
wild-type MLC20. (B) Immunostaining of S1A/S2A MLC20 stable
cells in the absent or presence of Dox. myc Ab (green), Alexa
Fluor546-phalloidin (red), and paxillin (blue). Bar, 25 m. (C) Quan-
tification of PDGF-induced the disassembly of stress fibers in MEF/
3T3 Tet-Off cells. *p  0.003 compared with controls (Dox) and
wild-type MLC20s. (D) Quantitative comparisons of the focal adhe-
sions in MEF/3T3 Tet-Off cells. #p  0.02 compared with controls
(Dox) and wild-type MLC20s. The values shown are means  SD
from three independent experiments (	300 cells; 100 cells/experi-
ment). The focal adhesion area were defined as follows: paxillin foci:
large focal adhesions, 3.22–16.05 m2 (6–30 pixels); and small focal
adhesions, 0.535–2.675 m2 (1–5 pixels).
Figure 6. Deletion of C-terminal heavy-chain phosphorylation
sites in the nonhelical tailpiece. (A) NIH3T3 cells were transfected
with either YFP-tagged wild-type or C-Myosin IIB. Twelve hours
after transfection, the cells were serum-starved for 18 h and then the
starved transfected cells were treated with 20 ng/ml PDGF for 30
min, followed by staining with Alexa Fluor546-phalloidin for visu-
alizing F-actin. Bar, 25 m. (B) The bar graphs show quantification
of PDGF-induced disassembly of stress fibers in NIH3T3 cells trans-
fected with YFP-wild-type Myosin IIB or C-Myosin IIB. Trans-
fected cells (n  40–65) were analyzed in three independent exper-
iments (wild type, n 165; C, n 137; p	 0.98, t tests). The values
shown are means  SD from three independent experiments.
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the inhibition of signaling downstream of RhoA (Guasch et
al., 1998; Riento et al., 2005). Other Rho family members Rac
and Cdc42 have also been shown to be transiently activated
by PDGF stimulation that lead to the down-regulation of
RhoA activity thus attenuating the stress fiber formation
(Sander et al., 1999; Jimenez et al., 2000). On the basis of these
observations together with our present data, we propose
that the PKC-dependent down-regulation of myosin motor
activity and the down-regulation of RhoA concertedly con-
trol the change in actin cytoskeletal structure upon PDGF
stimulation (Figure 7B).
How does the phosphorylation at the inhibitory sites in-
duce disassembly of stress fiber and the decrease in the focal
adhesion? It was previously reported that the phosphoryla-
tion at the inhibitory sites inhibits the motor activity of
myosin II phosphorylated at the activation sties, but not the
myosin filament formation (Nishikawa et al., 1984; Ikebe et
al., 1987; Ikebe and Reardon, 1990). Therefore, we think that
the inhibition of myosin II motor activity by the phosphor-
ylation of MLC20 at the inhibitory sites is in part responsible
for the PDGF-induced disassembly of stress fibers and the
decrease in the focal adhesion. Supporting this view, bleb-
bistatin, a specific inhibitor of actin-activated myosin II
ATPase activity but not the filament formation, blocked the
formation of actomyosin stress fibers and focal adhesions
(Straight et al., 2003; Kovacs et al., 2004; Hotulainen and
Lappalainen, 2006). This result suggests that the myosin
motor activity is critical for the formation of stress fibers and
focal adhesions. In favor of this view, Burridge and cowork-
ers suggested that the activation of myosin II activity pro-
duces the force driving the formation of stress fibers and
focal adhesions (Chrzanowska-Wodnicka and Burridge,
1996). Because stress fibers are thought to attach to the focal
adhesions that provide the force required for anchoring
them to the cell matrix (Geiger and Bershadsky, 2001; Geiger
et al., 2001), it is therefore likely that the decrease in the
myosin II–driven force by the phosphorylation of MLC20 at
the inhibitory sites influences the formation of focal adhe-
sions as well as the stress fibers.
Previous in vitro biochemical studies have suggested that
the phosphorylation of myosin II at the nonhelical tail plays
a role in the disassembly of myosin filamentous structures
(Murakami et al., 1998, 2000; Dulyaninova et al., 2005). In the
present study, the expression of S1A/S2A MLC20 attenuated
the PDGF-induced disassembly of stress fibers (Figure 5),
whereas the expression of C-Myosin IIB did not signifi-
cantly change the disassembly of stress fibers (Figure 6). It
was recently reported that phosphorylation of nonmuscle
myosin heavy-chain (MHC)-II-B at the tail by atypical PKC
zeta (aPKC) destabilizes the myosin IIB filaments in an
epidermal growth factor (EGF)-dependent manner (Even-
Faitelson and Ravid, 2006). However, aPKC did not phos-
phorylate the MLC20 (Varlamova et al., 2001). It is therefore
likely that the phosphorylation of MLC20 and MHC by PKC
isoforms are differentially involved in the reorganization of
actomyosin filaments during the cell motile events modu-
lated based on the types of extracellular stimuli. Interest-
ingly, it was reported that bradykinin and EGF-mediated
MHC-IIA and -IIB phosphorylation is associated with a loss
of cortical myosin II (van Leeuwen et al., 1999; Straussman et
al., 2001). These previous works also suggest that MHC
phosphorylation is involved in the regulation of microfila-
ment disassembly in the cell cortex. Taking these findings
together, it is plausible that the phosphorylation of MLC20 at
the inhibitory sites and MHC phosphorylation at the non-
helical tail play distinct roles in the actomyosin dynamics in
different spatial domains in cells. This view is supported by
the recent report showing that the expressed MHC-IIB, in
Figure 7. Model for the role of myosin II phos-
phorylation in a negative and positive manner.
(A) The generation of force by the complex of
actin and active form of myosin II stabilizes the
actomyosin filaments and focal adhesions. (B)
The effects of stimulation of the cells with PDGF.
PDGF transiently activates PKC and Rho GT-
Pase family (RhoE, Rac, and Cdc42) resulting in
the down-regulation of myosin II and RhoA ac-
tivities, which contributes to the reorganization
of actin cytoskeleton.
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which the PKC phosphorylation sites were converted to Asp
residues, was able to localize at the stress fibers, but this
mutation attenuated the localization of the mutant MHC-IIB
to the cell cortex (Rosenberg and Ravid, 2006). Moreover, it
was recently reported that myosin II isoforms (IIA and IIB)
differentially contributes to the cell motility (Even-Ram et al.,
2007; Vicente-Manzanares et al., 2007), suggesting that my-
osin isoforms are regulated by distinct mechanisms in motile
cells. Supporting this notion, biochemical studies revealed
that phosphate incorporation of MHC-IIB by PKC is much
faster than that of myosin IIA and, in contrast, that filament
assembly of myosin IIA is regulated by its binding protein
(Mts1) but not that of myosin IIB (Murakami et al., 1998,
2000; Dulyaninova et al., 2005). To clarify the roles of phos-
phorylation of MLC20 and MHC on actomyosin dynamics in
distinct cellular domains will be the subjects of future work.
On the basis of our findings, together with the results of
previous studies, we propose a model for reorganization of
actomyosin structure upon PDGF stimulation in the cells
(Figure 7). The initial stage of the PDGF receptor stimulation
is the dynamic cytoskeletal rearrangement involving a de-
crease in the stress fiber and a reduction in the focal adhe-
sion complexes (Bockus and Stiles, 1984; Heldin et al., 1998).
Present results suggest that the down-regulation of myosin
II activity via the phosphorylation of MLC20 at the Ser1/Ser2
sites is the factor determining reorganization of actomyosin
structure in this process. It has been thought that the me-
chanical force linking the focal adhesion and the cytoskele-
ton influences the stress fiber formation, and we think that
the down-regulation of the contractile activity of myosin II
by PDGF-mediated phosphorylation at the Ser1/Ser2 sites
facilitates the normal disassembly of the stress fibers and the
actin cytoskeletal reorganization. The later stage of PDGF
receptor stimulation is the promotion of cell motility. The
force generated by the activation of myosin II motor activity
is thought to be essential for this motile process. Recently,
we found that the disruption of zipper-interacting protein
(ZIP) kinase by siRNA decreases the myosin II phosphory-
lation at the activation sites and leads to the inhibition of
PDGF-induced cell migration as well as wound healing of
NIH3T3 cells (Komatsu and Ikebe, 2004). Taken together
with the present study, we conclude that the regulation of
myosin II, in both negative and positive manner, controls the
reorganization of the actomyosin filament and the genera-
tion of motile force via modulating the motor activity and
myosin filament stability.
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